PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)
$7.64 -0.14 (-1.7995%)
Analysed PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) News Sources
Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?
08-04-2026
yahoo.com
US Market's Hidden Gems: 3 Undiscovered Small Caps with Strong Potential
07-04-2026
yahoo.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02-04-2026
yahoo.com
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
01-04-2026
yahoo.com
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?
23-03-2026
fool.com
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why
18-03-2026
yahoo.com
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?
12-03-2026
yahoo.com
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
27-02-2026
yahoo.com
Puma Biotechnology, Inc. Q4 2025 Earnings Call Summary
27-02-2026
moby.co
Puma Biotechnology Q4 Earnings Call Highlights
27-02-2026
marketbeat.com
What is the current price of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)?
The current price of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) is $7.64.
PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) absolute price change since previous trading day?
The absolute price change of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) since the previous trading day is $-0.14.
PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) percentage price change since previous trading day?
The percentage price change of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) since the previous trading day is -1.7995%.
What is the most recent average sentiment score for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)?
The most recent average sentiment score for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)?
The most recent sentiment for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) is .
SEC-8K** Filing Available For PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.